HCM
RVPH

Highbridge Capital Management’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Highbridge Capital Management’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$556K Buy
+762,236
New +$3.47M 0.02% 159

Other funds holding RVPH

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Highbridge Capital Management's RVPH Position: Q1 2026 in Review

Highbridge Capital Management opened a new position in REVIVA PHARMA HLDGS INC (RVPH) in Q1 2026: 762,236 shares worth $556K. The stake represents 0.02% of the portfolio and ranks #159 among its holdings.

35 funds tracked by Wall St. Rank hold RVPH as of Q1 2026.

  • Highbridge Capital Management held 762,236 shares of REVIVA PHARMA HLDGS INC worth $556K as of Q1 2026.
  • REVIVA PHARMA HLDGS INC was a new Highbridge Capital Management position in Q1 2026.
  • REVIVA PHARMA HLDGS INC made up 0.02% of Highbridge Capital Management's portfolio in Q1 2026, its #159 holding.
  • 35 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q1 2026.

Based on Highbridge Capital Management's 13F filing for Q1 2026, filed 15 May 2026.